Healthy volunteers

100 total trials 11 recruiting

Filter these 100 trials by phase, country, sponsor and more.

Open in Search →

Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults. Ended

2024-515285-14-00 1 2025-03-04
Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin Ended

2024-520303-62-00 2 2025-03-04
Randomized, crossover, comparative bioavailability study of two Paracetamol-Ibuprofen 25-20 mg/ml oral suspension, administered in single do … Ended

2024-519661-22-00 3 2025-03-03
Randomized, open-label clinical trial (Phase 1) to evaluate safety, tolerability, pharmacokinetics and food effects of a single dose of IM-2 … Ended

2024-518155-37-00 3 2025-02-14
Bioequivalence clinical trial of two formulations of vortioxetine. Ended

2024-519398-21-00 2 2025-01-30
Bioequivalence study of GP-IMP-001 with regards to reference product Ended

2024-515889-14-00 2 2025-01-22
Bioequivalence clinical trial of two formulations of linagliptin/metformin. Ended

2024-516081-11-00 2 2024-12-13
KF2024#1 trial: Esketamine interaction study Ended

2024-516892-34-00 2 2024-12-03
Bioequivalence clinical trial of two formulations of linagliptin/metformin Ended

2024-515076-13-00 2 2024-11-19
A Single Dose, Non-randomised, Open-label, Parallel Group Study to Assess the Pharmacokinetics, Safety, and Tolerability of AZD4144 in Parti … Ended

2024-513848-28-00 3 2024-11-11
Bioequivalence clinical trial of two formulations of loperamide. Ended

2024-515531-29-00 2 2024-11-04
Study with healthy volunteers to investigate the safety, tolerability, blood concentration and some effects of various amounts of the pharma … Ended

2023-507753-15-00 3 2024-10-08
Randomized, crossover, two-period, comparative bioavailability study of two ibuprofen (arginate) formulations, administered as solutions in … Ended

2024-514478-37-00 3 2024-10-04
Bio-equivalence of Rosuvastatin 10 mg Ended

2023-509661-21-00 2 2024-10-03
Bioequivalence clinical trial of two formulations of bilastine. Ended

2024-515077-96-00 2 2024-09-13
YF_PROTECT: Prophylactic treatment with sofosbuvir for Yellow Fever Ended

2024-510949-34-00 6 2024-09-11
A study to learn how zilucoplan moves throughout the body over time when given in 2 different ways in healthy adults Ended

2023-508388-64-00 2 2024-08-05
Bioequivalence clinical trial of two formulations of dapagliflozin. Ended

2023-506561-62-00 2 2024-07-01
Bioequivalence clinical trial of two formulations of linagliptin Ended

2023-506562-31-00 2 2024-06-14
Bioequivalence clinical trial of two formulations of edoxaban. Ended

2024-510795-20-00 2 2024-06-11
A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Ver … Ended

2023-509749-11-00 2 2024-06-05
A study to compare the pharmacokinetics of salbutamol administered via metered dose inhalers containing propellants HFA-152a (test) or HFA-1 … Ended

2023-508279-36-00 3 2024-05-22
Study of excretion of CORTICOSTEROIDS to improve their detection in Anti-doping controls. Ended

2023-508221-27-02 3 2024-04-19
Randomized, crossover, two-period, two-treatment, comparative bioavailability study of ibuprofen (arginine) granules for oral solution, deve … Ended

2023-509219-97-00 3 2024-04-01

Showing 49–72 of 100 trials